Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: To investigate the independent effects of irisin on insulin resistance (IR) in ovary of polycystic ovary syndrome (PCOS) and explore possible pathways.

Methods: We established PCOS medel using Poretsky L's method, then PCOS rats were randomly divided into model group (M) and irisin group (I), and normal rats (N) were used as the control. Then rats in the group I were injected with recombinant irisin. Then the levels of circulating fasting blood glucose (FBG), fasting insulin (FINS), homeostasis model assessment of IR (HOMA-IR) and PI3K/AKT and MAPK/ERK pathways in each group were observed, as well as the effects of irisin on the levels of circulating HOMA-IR and PI3K/AKT and MAPK/ERK pathways in ovary of PCOS rats were evaluated.

Results: Compared with normal group, levels of FBG, FINS, and HOMA-IR of model group were significantly increased (p < 0.001, p < 0.001, and p < 0.001, respectively), levels of average optical density by IHC of p-PI3K, PI3K, p-AKT, and AKT (p = 0.015, p = 0.010, p = 0.005, and p = 0.009, respectively) and levels of mRNA concentration of PI3K and AKT (p = 0.001, and p = 0.005, respectively) were decreased, while the levels of average optical density of p-ERK, ERK (p = 0.011, and p = 0.013, respectively) and level of mRNA concentration of ERK (p < 0.001) were increased in ovary. After irisin intervention, compared with model group, levels of FBG, FINS, and HOMA-IR of rats in irisin group were significantly decreased (p = 0.001, p < 0.001, and p < 0.001, respectively), levels of average optical density by IHC of p-PI3K, PI3K, p-AKT, and AKT (p = 0.030, p = 0.024, p = 0.012, and p = 0.025, respectively) and levels of mRNA concentration of PI3K and AKT (p = 0.002, and p = 0.003, respectively) were significantly increased, while the levels of average optical density of p-ERK, ERK (p = 0.004, and p = 0.026, respectively) and level of mRNA concentration of ERK (p = 0.001) were significantly decreased.

Conclusion: Our study demonstrated that irisin could not only improve circulating insulin resistance, but may also improve ovarian IR through an increase in the activity of PI3K/AKT signaling and a decrease of MAPK/ERK signaling.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jog.16076DOI Listing

Publication Analysis

Top Keywords

polycystic ovary
8
ovary syndrome
8
effects irisin
8
pcos rats
8
model group
8
irisin levels
8
levels circulating
8
homa-ir pi3k/akt
8
pi3k/akt mapk/erk
8
mapk/erk pathways
8

Similar Publications

Combination of Si@UiO-66-NH paper-based thin film microextraction with direct solid-state spectrofluorimetry for extraction and determination of estradiol in urine.

Anal Chim Acta

November 2025

Department of Analytical Chemistry, Faculty of Chemistry, Alzahra University, Vanak, Tehran, Iran; Analytical and Bioanalytical Research Centre, Alzahra University, Vanak, Tehran, Iran. Electronic address:

Background: Determination of the estradiol hormone in urine is crucial for evaluating congenital adrenal hyperplasia, certain hormone-producing ovarian tumors, polycystic ovary syndrome, liver disease, pregnancy, and infertility. On the other hand, steroid hormones can have destructive effects on the environment, animals, and the endocrine system of humans. Consequently, accurately measuring this hormone's concentration in trace amounts is essential for environmental safety and human health.

View Article and Find Full Text PDF

Background: Polycystic ovary syndrome (PCOS) is characterized by reproductive and endocrine abnormalities.

Objective: The present study aimed to assess the effect of oral contraceptive pills (OCPs) and vitamin D3 on sexual dysfunction in women with PCOS and vitamin D3 deficiency.

Materials And Methods: This randomized double-blind placebo-controlled clinical trial was conducted in Iran between January and April 2019.

View Article and Find Full Text PDF

Objective: This present study aimed to measure platelet factor 4 (PF4) protein level in follicular fluid of patients with polycystic ovary syndrome (PCOS) and analyzed the correlation between follicular PF4 level with clinical characteristics.

Methods: Sixty-seven women (36 PCOS patients vs. 31 non-PCOS women) were enrolled in the study.

View Article and Find Full Text PDF

Polycystic ovary syndrome: A metabolic disorder with therapeutic opportunities.

Cell Metab

August 2025

State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, Shandong 250012, China; National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Sha

Polycystic ovary syndrome (PCOS) is a highly prevalent endocrine disorder characterized by intertwined reproductive and metabolic abnormalities. While its causal origins remain incompletely understood, accumulating evidence suggests metabolic dysfunctions-manifested by insulin resistance, obesity, hyperglycemia, and dyslipidemia-as key contributors to the pathogenesis and progression of PCOS. Emerging interventions targeting these metabolic disturbances, including caloric restriction, GLP-1-based therapies, and bariatric surgery, have shown efficacy in alleviating PCOS symptoms and potentially blocking their inheritance.

View Article and Find Full Text PDF

Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder associated with vascular dysfunction and increased cardiovascular risk. This study aims to investigate the dysregulation of vascular tone in PCOS, focusing on the imbalance between vasodilators (nitric oxide [NO] and apelin) and vasoconstrictors (noradrenaline and reduced prostacyclin). By examining these factors, the study seeks to elucidate their contribution to endothelial dysfunction and cardiovascular complications in PCOS patients.

View Article and Find Full Text PDF